article thumbnail

NCIA Event, June 13: Paul Coble Moderates Panel on Testing and Labeling for “Minor Cannabinoid” Products

Canna Law Blog

We are pleased to announce Paul Coble as a panelist moderator for the National Cannabis Industry Association (NCIA) webinar event this coming Tuesday, Jun 13, 2023 at 12:00 PM. The event is titled, From Lab to Label: Safegaurding Consumers in the Cannabinoid Product Landscape.

Events 72
article thumbnail

Developing Regulations Surrounding Novel Cannabinoids

Cannabis Law Report

We apply our entirely subjective bong score to each event. You have been seeing and hearing about it everywhere lately — but what are novel cannabinoids like Delta-8, and what does the increasing proliferation of products containing them mean for state and federal policymakers? 1 Don’t Bother Unless You Need A Well Deserved Sleep.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

Adverse events were mostly mild and resolved spontaneously. A 2017 literature review by the National Academy of Sciences, Engineering, and Medicine concluded , “There is conclusive or substantial evidence that cannabis or cannabinoids are effective for the treatment of chronic pain in adults.”

article thumbnail

Replacing Ice with Cannabinoids: Numbing Pains

Cannabis Life Network

Therapy by numbing is an obvious asset, but a more intricate event occurs. The act of icing and applying heat to an injury falls deeply in tune with cannabinoid therapy. The post Replacing Ice with Cannabinoids: Numbing Pains appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Stocks.

article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, 0.59, 95% CI [0.36–0.97]),

Safety 52
article thumbnail

New hemp bills in conflict with IDOA proposed amendments

Illinois News Joint

The definition THC does not include CBD, CBG, CBN, delta-7 THC, delta-8, THC, delta-10 THC, THCa, THCv, THCva, and other yet to be discovered cannabinoids.” To find cannabis-friendly events in Illinois, visit here. The key definition in HB5306 and SB3790 states, “‘THC’ means delta-9 tetrahydrocannabinol. La Shawn K.

Hemp 91
article thumbnail

Organigram Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company

Cannabis Law Report

With growing interest in sustainable and bio-based cannabinoids, and after completing a strategic review of Hyasynth including their intellectual property (IP) and R&D platforms, Organigram remains excited about Hyasynth’s future and growth plans. million of secured convertible debentures in Hyasynth (the “Debentures”).